{
    "study_accession": "SDY21",
    "actual_completion_date": "2010-05-30",
    "actual_enrollment": 4,
    "actual_start_date": "2007-08-01",
    "age_unit": "Not Specified",
    "brief_description": "Microarray and Luminex assays.",
    "brief_title": "Gene Expression Study of TLR Responses on Dendritic Cells",
    "clinical_trial": "N",
    "condition_studied": "LPS, CpG and Papain",
    "dcl_id": 2,
    "description": "Cytokine and gene expression profile after TLR activation of dendritic cells.",
    "doi": "10.21430/M3YUM4W1N9",
    "endpoints": "Microarray and Luminex assays.",
    "gender_included": "Female, Male",
    "hypothesis": "The innate immune responses following TLR receptor activation are driven at the transcription level, and lead to the modulation of transcription of a big group of genes.",
    "initial_data_release_date": "2014-01-17",
    "initial_data_release_version": "DR7",
    "intervention_agent": "FTL3\r",
    "latest_data_release_date": "2014-01-17",
    "latest_data_release_version": "DR7",
    "maximum_age": null,
    "minimum_age": null,
    "objectives": "Characterization of the cytokine/chemokine and gene expression profile after TLR receptor activation.",
    "official_title": "Gene Expression Study of TLR Responses on Dendritic Cells",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 1885,
    "research_focus": [
        "Immune Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM316",
            "description": "C57BL6/J female mice, FLT3-L treatment, 20ug/200ul/mouse/day for 9days",
            "name": "FLT3 treated B6 mice"
        },
        {
            "arm_accession": "ARM317",
            "description": "p53-knockout C57BL/6 mouse, donor of JAWS II cell line, GM-CSF-dependent DC line established from bone marrow cells",
            "name": "mice for JAWS II cell line"
        }
    ],
    "personnel": [
        {
            "first_name": "Thomas",
            "last_name": "Kepler",
            "organization": "Duke Human Vaccine Institute",
            "role_in_study": "Principal Investigator",
            "site_name": "Duke Human Vaccine Institute\r"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Modeling Immunity for Biodefense I",
            "contract_name": "Multiscale Systems Immunology for Adjuvant Development"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Luminex xMAP",
            "number_of_expsamples": 5612
        },
        {
            "measurement_technique": "Transcription profiling by array",
            "number_of_expsamples": 150
        }
    ],
    "subject": {
        "race": [],
        "gender": []
    }
}
